Kamena K. Kostova

Kamena K. Kostova

Auto-generated profile, based on publicly available information

Kamena K. Kostova

Stowers Institute for Medical Research

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Molecular Cell
Verified
Journal Article
Closed access
KHKelsey L. Hickey
Kelsey L. Hickey
KDKimberley Dickson
Kimberley Dickson
JCJ. Zachery Cogan
J. Zachery Cogan
JRJoseph M. Replogle
Joseph M. Replogle
MSMichael Schoof
Michael Schoof
KKKamena K. Kostova
Kamena K. Kostova

28 July 2017 in Science
Verified
Journal Article
Closed access
PDF file
KKKamena K. Kostova
Kamena K. Kostova
KHKelsey L. Hickey
Kelsey L. Hickey
BOBeatriz A. Osuna
Beatriz A. Osuna
JHJeffrey A. Hussmann
Jeffrey A. Hussmann
AFAdam Frost
Adam Frost
JWJonathan S. Weissman
Jonathan S. Weissman
A tale of CAT tails: When protein translation fails, the incomplete nascent polypeptide is targeted for degradation by the highly conserved ribosome-associated quality control complex (RQC). Mutations in RQC components lead to stress at the cellular level and neurodegeneration at the organismal level. Recent studies have shown that RQC tags partially synthesize proteins with C-terminal alanine and threonine (CAT) tails in an unusual elongation reaction. Working in yeast, Kostova et al. elucidated the role of this process. CAT-tailing is a fail-safe mechanism to ensure the degradation of partially synthesized proteins. The elongation process appears to “push” lysines out of the ribosome exit tunnel, which allows them to be marked by ubiquitin degradation signals. Science , this issue p. 414

5 May 2025 in Molecular Cell
Verified
Journal Article
Closed access
JAJared F. Akers
Jared F. Akers
MLMichael LaScola
Michael LaScola
ABAdrian Bothe
Adrian Bothe
HSHanna Suh
Hanna Suh
CJCarmen Jung
Carmen Jung
KKKamena K. Kostova
Kamena K. Kostova

3 October 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
KHKelsey L. Hickey
Kelsey L. Hickey
KDKimberley Dickson
Kimberley Dickson
JCJ. Zachery Cogan
J. Zachery Cogan
JRJoseph M. Replogle
Joseph M. Replogle
MSMichael Schoof
Michael Schoof
KKKamena K. Kostova
Kamena K. Kostova
Summary: R ibosome-associated Q uality C ontrol (RQC) pathways protect cells from toxicity caused by incomplete protein products resulting from translation of damaged or problematic mRNAs. Extensive work in yeast has identified highly conserved mechanisms that lead to the degradation of the faulty mRNA and partially synthesized polypeptide. Here, we used CRISPR-Cas9-based screening to search for additional RQC strategies in mammals. We found that failed translation leads to specific silencing of translation initiation on that message. This negative feedback loop is mediated by two translation inhibitors, GIGYF2 and 4EHP. Their recruitment to defective messages can be mediated by different factors, including potentially the collision sensor ZNF598. Both model substrates and growth-based assays established that inhibition of additional rounds of translation acts in concert with known RQC pathways to prevent buildup of toxic proteins. Inability to block translation of faulty mRNAs, and subsequent accumulation of partially synthesized polypeptides, could explain the neurodevelopmental and neuropsychiatric disorders observed in mice and humans with compromised GIGYF2 function.

29 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JAJared F. Akers
Jared F. Akers
ABAdrian Bothe
Adrian Bothe
HSHanna Suh
Hanna Suh
CJCarmen Jung
Carmen Jung
ZSZachary Stolp
Zachary Stolp
KKKamena K. Kostova
Kamena K. Kostova
Eukaryotic ribosome assembly is an intricate process that involves four ribosomal RNAs, 80 ribosomal proteins, and over 200 biogenesis factors that take part in numerous interdependent steps. This complexity creates a large genetic space in which pathogenic mutations can occur. “Dead-end” ribosome intermediates that result from biogenesis errors are rapidly degraded, affirming the existence of quality control pathway(s) that monitor ribosome assembly. However, the factors that differentiate between on-path and dead-end intermediates are unknown. We engineered a system to perturb ribosome assembly in human cells and discovered that faulty ribosomes are degraded via the ubiquitin proteasome system. We identified ZNF574 as a key component of a novel quality control pathway, which we term the Ribosome Assembly Surveillance Pathway (RASP). Loss of ZNF574 results in the accumulation of faulty biogenesis intermediates that interfere with global ribosome production, further emphasizing the role of RASP in protein homeostasis and cellular health.

20 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RLRuoyu Li
Ruoyu Li
GMGrace McKown
Grace McKown
DTDai Tsuchiya
Dai Tsuchiya
MMMark Mattingly
Mark Mattingly
AGAnna Galligos
Anna Galligos
KKKamena K Kostova
Kamena K Kostova
Ribosome biogenesis is a conserved and highly regulated process that starts in the nucleolus, a membrane-less multi-phase organelle. Although the architecture of the nucleolus is known to change due to perturbations, how nucleolar organization is modulated during physiological processes to meet changing translational demands remains unclear. Here, we use zebrafish oogenesis as a developmental context requiring a rapid expansion of translational capacity to investigate the regulation of nucleolar architecture. We show nucleoli undergo coordinated changes in number, size, subnuclear localization, and layering throughout oogenesis. We further demonstrate that nucleoli form around extrachromosomal DNA circles that contain the rDNA locus. Notably, mouse oocytes undergo similar developmental changes in nucleolar layering and phase organization, indicating that remodeling of nucleolar condensates is a conserved feature of oogenesis. These findings reveal previously unexplored regulation of nucleolar architecture as developmental adaptations to changing biosynthetic needs.